We are live on ! Find out more
CGL

Clarius Group LLC Portfolio holdings

AUM $1.75B
1-Year Est. Return 19.04%
This Fund
S&P 500
This Quarter Est. Return
+6.98%
1 Year Est. Return
+19.04%
3 Year Est. Return
+92.07%
5 Year Est. Return
+98.79%
10 Year Est. Return
+415.93%
AUM
$238M
AUM Growth
-$5.15M
Cap. Flow
-$16.6M
Cap. Flow %
-6.98%
Top 10 Hldgs %
73.68%
Holding
100
New
5
Increased
11
Reduced
37
Closed
30

Top Sells

Rank Stock Value
1
PI icon
Impinj
PI
+$2.05M
2
SAGE
Sage Therapeutics
SAGE
+$1.57M
3
AAPL icon
Apple
AAPL
+$1.43M
4
AMZN icon
Amazon
AMZN
+$1.26M
5
MSFT icon
Microsoft
MSFT
+$856K

Sector Composition

Rank Sector Weight
1 Industrials 38.23%
2 Consumer Discretionary 14.01%
3 Healthcare 7.45%
4 Technology 4.99%
5 Communication Services 4.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMCSA icon
76
Comcast
CMCSA
$87.3B
-8,041
Closed -$313K
CSCO icon
77
Cisco
CSCO
$443B
-9,126
Closed -$285K
CVX icon
78
Chevron
CVX
$382B
-3,026
Closed -$316K
GS icon
79
Goldman Sachs
GS
$289B
-951
Closed -$211K
HD icon
80
Home Depot
HD
$337B
-2,309
Closed -$354K
IBM icon
81
IBM
IBM
$213B
-1,825
Closed -$268K
INTC icon
82
Intel
INTC
$413B
-7,078
Closed -$238K
JNJ icon
83
Johnson & Johnson
JNJ
$640B
-4,527
Closed -$599K
JPM icon
84
JPMorgan Chase
JPM
$916B
-5,306
Closed -$485K
MCD icon
85
McDonald's
MCD
$193B
-2,927
Closed -$448K
MMM icon
86
3M
MMM
$91.8B
-1,665
Closed -$290K
MO icon
87
Altria Group
MO
$125B
-2,704
Closed -$201K
MRK icon
88
Merck
MRK
$322B
-6,225
Closed -$381K
NVS icon
89
Novartis
NVS
$302B
-3,119
Closed -$233K
ORCL icon
90
Oracle
ORCL
$339B
-5,777
Closed -$290K
PEP icon
91
PepsiCo
PEP
$196B
-2,878
Closed -$333K
PFE icon
92
Pfizer
PFE
$143B
-14,015
Closed -$447K
PG icon
93
Procter & Gamble
PG
$340B
-3,047
Closed -$266K
PM icon
94
Philip Morris
PM
$309B
-2,635
Closed -$309K
SAN icon
95
Banco Santander
SAN
$191B
-11,923
Closed -$76K
UNH icon
96
UnitedHealth
UNH
$382B
-2,126
Closed -$394K
UNP icon
97
Union Pacific
UNP
$174B
-2,063
Closed -$225K
V icon
98
Visa
V
$701B
-2,988
Closed -$280K
XOM icon
99
ExxonMobil
XOM
$650B
-5,189
Closed -$419K
CELG
100
DELISTED
Celgene Corp
CELG
-1,576
Closed -$205K

Similar funds

Clarius Group LLC's Q3 2017 Portfolio in Review

As of Q3 2017, Clarius Group LLC held 100 positions worth $238M, down 2.1% from $243M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Clarius Group LLC withdrew a net $16.6M in Q3 2017, closing 30 positions and reducing 37 holdings. Its most notable exit was bluebird bio, an estimated $765K position sold in full.

By sector, the portfolio is most concentrated in Industrials at 38% of assets, up from 35% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Clarius Group LLC opened a new position in Berkshire Hathaway Class A worth $1.92M.

  • Clarius Group LLC's largest Q3 2017 buy was Berkshire Hathaway Class A: 7 shares worth $1.92M.
  • Clarius Group LLC added most to Vanguard Value ETF in Q3 2017, an estimated $1.25M increase.
  • Clarius Group LLC's biggest Q3 2017 reduction was Impinj, cutting an estimated $2.05M.
  • Clarius Group LLC fully exited bluebird bio in Q3 2017, selling an estimated $765K.
  • Clarius Group LLC's ten largest holdings make up 74% of its $238M portfolio in Q3 2017.
  • Clarius Group LLC opened 5 new positions and closed 30 in Q3 2017.
  • Clarius Group LLC's portfolio value fell 2.1% quarter-over-quarter to $238M.

Based on Clarius Group LLC's 13F filing for Q3 2017, filed 7 Nov 2017.